Tag: transplant diagnostics market

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The transplant diagnostics sector is experiencing significant growth fueled by advancements in medical technology and rising demand for organ transplantation procedures worldwide. As this field evolves, it is essential to understand the current market size, key growth drivers, major players, and future prospects shaping its trajectory.

Market Size and Growth Outlook for the Transplant Diagnostics Market

The transplant diagnostics market has demonstrated strong expansion in recent years. It is projected to increase from $2.07 billion in 2025 to $2.25 billion in 2026, reflecting an annual growth rate of 8.5%. This upward trend during the historical period is largely due to the rising number of organ transplant operations, progress in histocompatibility testing, a growing incidence of immunogenetic disorders, the establishment of more transplant centers, and government support for organ donation initiatives.

Looking ahead, the market is set to grow further, reaching an estimated $2.96 billion by 2030, with a compound annual growth rate (CAGR) of 7.1%. Factors driving this projected growth include the integration of artificial intelligence and machine learning in diagnostic testing, the adoption of next-generation sequencing (NGS) technologies, expansion in personalized immunotherapy treatments, the rise of cloud-based diagnostic platforms, and increased global awareness of organ donation. Key trends expected to influence the market during the forecast period involve faster histocompatibility testing, AI-enhanced donor-recipient matching, incorporation of molecular diagnostics, high-throughput screening methods, and cloud-based transplant data management systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

Primary Factors Catalyzing Growth in the Transplant Diagnostics Market

One significant factor propelling the transplant diagnostics market is the rising prevalence of chronic diseases. Chronic illnesses such as diabetes, heart disease, and arthritis are long-term conditions that often require continuous medical care and lifestyle adjustments. Their prevalence is increasing due to unhealthy habits including poor diet, lack of physical activity, and smoking, all of which raise the risk of these conditions.

Transplant diagnostics play a critical role in managing these diseases by enabling accurate monitoring of organ health and early detection of complications related to transplants. This technology supports better patient outcomes through timely clinical interventions, personalized treatment strategies, and improved long-term organ survival and healthcare management. For instance, in June 2024, the UK’s National Health Service reported an 18% increase in patients diagnosed with non-diabetic hyperglycemia or pre-diabetes, totaling 3,615,330 cases in 2023 compared to 3,065,825 in 2022. Such trends highlight how chronic disease prevalence is enhancing the demand for transplant diagnostics.

How the Transplant Diagnostics Market Is Organized Across Various Segments

This market is categorized into several segments to provide a detailed understanding:

1) By Type: Reagents and Consumables, Instruments, Software and Services

2) By Transplant Type: Solid Organ Transplant, Stem Cell Transplant

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non-Molecular Assay, Molecular Assay

5) By End User: Hospitals and Transplant Centers, Research Laboratories and Transplant Centers, Commercial Service Providers

Further breakdown includes subsegments such as PCR reagents, antibodies and antigens, sample collection kits, and control materials under reagents and consumables; flow cytometers, PCR machines, sequencers, and luminometers within instruments; as well as data analysis software, laboratory information management systems (LIMS), consulting, and technical support services under software and services.

Access The Complete Transplant Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Emerging Innovations Shaping Future Growth in Transplant Diagnostics

Leading companies are focusing on launching advanced transplant diagnostic services that enhance accuracy and efficiency in both pre-transplant and post-transplant testing. These cutting-edge offerings are designed to improve patient care and streamline diagnostic workflows.

For example, in March 2023, Quest Diagnostics introduced Quest Advanced Specialized Transplant Services in the United States. This comprehensive service portfolio includes over 170 specialized transplant and infectious disease tests, longitudinal trend analysis integrated into electronic medical records (EMRs), and 24/7 support with medical consultation to ensure proper test selection and interpretation. Additional features include patient-tailored educational materials and expedited testing at more than 2,100 patient service centers, with results for some tests available within 8 to 24 hours.

Top Competitors Driving the Transplant Diagnostics Market

Key players operating in this sector include F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieux S.A., Grafton Companies, Bio-Rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Luminex Corporation, CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, and several others. These companies continue to innovate and expand their service offerings to maintain competitive advantage.

Regional Breakdown Revealing Market Leaders and Growth Hotspots

In 2025, North America held the largest share of the transplant diagnostics market, reflecting strong demand and established healthcare infrastructure in the region. Western Europe ranked as the second-largest market. The analysis also covers other geographic areas including Asia-Pacific, South East Asia, Eastern Europe, South America, Middle East, and Africa, with growing interest in transplant diagnostics observed globally.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Transplant Diagnostics Market Between 2026 And 2030?

The transplant diagnostics market has experienced substantial growth in recent years. It is anticipated to expand from $2.07 billion in 2025 to $2.25 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. The expansion observed historically can be attributed to several factors, including the increasing number of organ transplantation procedures, progress in histocompatibility testing, a rising incidence of immunogenetic disorders, the proliferation of transplant centers, and government funding for organ donation programs.

The transplant diagnostics market size is projected to experience robust expansion in the coming years, reaching $2.96 billion by 2030 with a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is propelled by factors such as the integration of AI and machine learning into testing, the increasing adoption of next-generation sequencing (NGS), the expansion of personalized immunotherapy, the development of cloud-based diagnostics platforms, and a rise in global organ donation awareness. Significant trends expected in this period include rapid histocompatibility testing, AI-powered donor-recipient matching, enhanced molecular diagnostics integration, high-throughput screening techniques, and cloud-based systems for transplant data management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Which Drivers Are Supporting The Transplant Diagnostics Market Growth?

The escalating incidence of chronic illnesses is projected to stimulate the expansion of the transplant diagnostics market in the future. Chronic diseases are persistent health conditions that typically advance slowly over time, such as diabetes, heart disease, and arthritis, frequently demanding continuous medical care and lifestyle adjustments for symptom control and complication prevention. The rise in chronic diseases is largely attributable to unhealthy lifestyle choices, including poor nutrition, physical inactivity, and smoking, which heighten the risk of conditions like diabetes, heart disease, and obesity. Transplant diagnostics contribute to chronic disease management by facilitating precise monitoring of organ health and the early identification of transplant-related complications. These tools enhance patient outcomes by guiding timely interventions, supporting personalized treatment plans, and improving long-term organ survival and overall healthcare management. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Thus, the growing prevalence of chronic diseases is propelling the growth of the transplant diagnostics market.

How Are Segments Identified Within The Transplant Diagnostics Market Segment Framework?

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent And Consumables, Instrument, Software And Services

2) By Transplant Type: Solid Organ, Stem Cell

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non Molecular Assay, Molecular Assay

5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers

Subsegments:

1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials

2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

Which Trends Are Expected To Impact The Transplant Diagnostics Market?

Leading companies within the transplant diagnostics market are focused on launching sophisticated transplant diagnostics services to maximize their market profitability. Advanced transplant diagnostic services encompass the utilization of novel and cutting-edge diagnostic tools and technologies to enhance the accuracy and efficiency of both pre-transplant and post-transplant testing. For instance, in March 2023, Quest Diagnostics, a US-based medical laboratory company, introduced Quest Advanced Specialized Transplant Services, a comprehensive collection of innovative diagnostics and support services designed to increase access to laboratory tests for solid organ, human cell, and tissue transplants. This offering features an extensive selection of more than 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test outcomes within a doctor’s electronic medical record (EMR), and round-the-clock support services, including medical consultation to ensure proper test selection and result interpretation impacting care. These new services build upon Quest’s prior offerings in transplant testing with added capabilities. Such capabilities include new patient-customized information packets to help educate patients on the procedure and to assist Quest’s phlebotomists in fast-tracking testing for patients visiting one of Quest’s 2,100 patient service centers. Results for some tests can be obtained within 8–24 hours.

Who Are The Companies Competing Within The Transplant Diagnostics Market?

Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

Get The Full Transplant Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Which Region Leads The Transplant Diagnostics Market In Terms Of Market Share?

North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Transplant Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Transplant Diagnostics Market 2026, By The Business Research Company

Diagnostic Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-equipment-global-market-report

Diagnostic And Monitoring Ophthalmic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

Microbiology Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Transplant Diagnostics Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The transplant diagnostics market size has observed substantial growth in recent years. It is anticipated to expand from $2.07 billion in 2025 to $2.25 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. The growth witnessed historically can be attributed to a surge in organ transplantation procedures, advancements in histocompatibility testing, an increasing occurrence of immunogenetic disorders, the expansion of transplant centers, and governmental funding for organ donation programs.

The transplant diagnostics market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $2.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is attributable to factors such as the incorporation of AI and machine learning into testing, the widespread adoption of next-generation sequencing (NGS), the broadening scope of personalized immunotherapy, the emergence of cloud-based diagnostics platforms, and increased global awareness of organ donation. Key developments expected during this period include swift histocompatibility testing, AI-driven donor-recipient matching, the integration of molecular diagnostics, advanced high-throughput screening methods, and cloud-based systems for managing transplant data.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Transplant Diagnostics Market?

The rising incidence of chronic diseases is projected to stimulate the expansion of the transplant diagnostics market in the future. Chronic diseases are enduring health conditions, such as diabetes, heart disease, and arthritis, which typically progress slowly and often demand continuous medical attention and lifestyle modifications to manage symptoms and prevent complications. The increase in chronic diseases is largely attributable to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which elevate the risk of conditions like diabetes, heart disease, and obesity. Transplant diagnostics assist in managing chronic diseases by enabling precise monitoring of organ health and the early identification of transplant-related complications. They enhance patient outcomes through guiding timely interventions, supporting personalized treatment plans, and improving long-term organ survival and overall healthcare management. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, which signifies an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of chronic diseases is a key driver for the transplant diagnostics market’s growth.

What Major Segment Divisions Exist Within The Transplant Diagnostics Market?

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent And Consumables, Instrument, Software And Services

2) By Transplant Type: Solid Organ, Stem Cell

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non Molecular Assay, Molecular Assay

5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers

Subsegments:

1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials

2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

How Are Trends Shaping The Direction Of The Transplant Diagnostics Market?

Leading companies in the transplant diagnostics market are concentrating on introducing sophisticated transplant diagnostics services to maximize their market profits. Advanced transplant diagnostic services refer to the utilization of novel and cutting-edge diagnostic tools and technologies to enhance the precision and efficiency of testing conducted before and after transplantation. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory firm, launched Quest Advanced Specialized Transplant Services, a broad array of innovative diagnostics and support services designed to improve access to laboratory tests for solid organ, human cell, and tissue transplants. This offering features a comprehensive selection of more than 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test outcomes within the doctor’s electronic medical record (EMR), and continuous support services, including medical consultations to ensure appropriate test selection and result interpretation affecting patient care. The new services enhance Quest’s prior transplant testing offerings with additional capabilities. These capabilities involve new patient-tailored information packets to help educate patients about the process and assist Quest’s phlebotomists in expediting testing for patients visiting any of Quest’s 2,100 patient service centers. Results for specific tests can be acquired within 8–24 hours.

Which Companies Are Leading Innovation In The Transplant Diagnostics Market?

Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

Read the full transplant diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

What Are The Leading Geographic Regions In The Transplant Diagnostics Market?

North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Transplant Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2481&type=smp

Browse Through More Reports Similar to the Global Transplant Diagnostics Market 2026, By The Business Research Company

Diagnostic Imaging Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-equipment-global-market-report

Diagnostic And Monitoring Ophthalmic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

Microbiology Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Transplant Diagnostics Market’s size between 2026 and 2030?

The transplant diagnostics market has demonstrated robust growth in recent years. It is projected to expand from $2.07 billion in 2025 to $2.25 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. Historically, this growth has been primarily attributed to factors such as an increase in organ transplantation procedures, advancements in histocompatibility testing, the rising prevalence of immunogenetic disorders, the expansion of transplant centers, and government funding for organ donation programs.

The transplant diagnostics market is poised for significant growth in the coming years, with its size projected to reach $2.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This anticipated growth during the forecast period is fueled by the integration of AI and machine learning in testing, the increasing adoption of next-generation sequencing (NGS), the expansion of personalized immunotherapy, the emergence of cloud-based diagnostics platforms, and heightened global awareness surrounding organ donation. Key trends expected in this period include rapid histocompatibility testing, AI-powered donor-recipient matching, comprehensive molecular diagnostics integration, advanced high-throughput screening techniques, and efficient cloud-based transplant data management solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

Which Drivers Are Shaping Strategic Decisions In The Transplant Diagnostics Market?

The escalating occurrence of chronic diseases is anticipated to drive the future growth of the transplant diagnostics market. These enduring health conditions, such as diabetes, heart disease, and arthritis, typically progress slowly and demand continuous medical attention and lifestyle modifications to manage symptoms and prevent complications. The rise in chronic diseases is largely attributed to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which heighten the risk of conditions like diabetes, heart disease, and obesity. Transplant diagnostics assist in chronic disease management by enabling precise monitoring of organ health and early detection of transplant-related complications. They improve patient outcomes by guiding timely interventions, supporting personalized treatment plans, and enhancing long-term organ survival and overall healthcare management. For instance, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. Thus, the increasing prevalence of chronic diseases is a significant driver for the growth of the transplant diagnostics market.

What Segment Categories Are Covered In The Transplant Diagnostics Market?

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent And Consumables, Instrument, Software And Services

2) By Transplant Type: Solid Organ, Stem Cell

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non Molecular Assay, Molecular Assay

5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers

Subsegments:

1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials

2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

What Upcoming Trends Are Likely To Define The Future Path Of The Transplant Diagnostics Market?

Leading companies within the transplant diagnostics market are concentrating on introducing advanced transplant diagnostics services to maximize their profits. Such advanced transplant diagnostic services involve employing novel and sophisticated diagnostic tools and technologies to enhance the accuracy and efficiency of both pre-transplant and post-transplant testing. For instance, in March 2023, Quest Diagnostics, a US-based medical laboratory company, launched Quest Advanced Specialized Transplant Services. This extensive collection of innovative diagnostics and support services was created to increase access to lab tests for solid organ, human cell, and tissue transplants. It offers a thorough selection of more than 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results accessible in the doctor’s electronic medical record (EMR), and round-the-clock support services, including medical consultation to ensure appropriate test selection and result interpretation affecting care. These new services build upon Quest’s prior offerings in transplant testing with added capabilities. These capabilities include new patient-customized information packets designed to educate patients on the process and to help Quest’s phlebotomists fast-track testing for patients visiting one of Quest’s 2,100 patient service centers. Results for certain tests can be obtained within 8–24 hours.

Which Major Firms Are Strengthening Their Position In The Transplant Diagnostics Market?

Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Transplant Diagnostics Market?

North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Transplant Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2481&type=smp

Browse Through More Reports Similar to the Global Transplant Diagnostics Market 2026, By The Business Research Company

Diagnostic Imaging Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-equipment-global-market-report

Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Transplant Diagnostics Market Expected to Grow Between 2025 And 2029?

In the past few years, the transplant diagnostics market has seen consistent growth. The market is projected to increase from $2.01 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 3.0%. Factors contributing to this growth during the historical period include the development of HLA typing, an increase in organ transplantations, advancements in immunosuppressive therapy, the introduction of cross-matching techniques, and regulatory standardization.

What Growth Rate Is Anticipated for the Transplant Diagnostics Market in the Coming Years?

A robust expansion in the transplant diagnostics market size is anticipated in the upcoming years. The market is projected to reach $2.75 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.4%. The impressive growth during the forecast period can be linked to patient-oriented strategies, regulatory changes, an increase in live donor transplants, the advancement of customized transplant medicine, and the burgeoning transplant procedures. Key trends during this forecast period encompass educational and awareness initiatives, market proliferation strategies, evolution of regulatory guidelines, perfection of immunosuppressive therapy, and development of biomarkers.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

Who Are the Leading Companies in the Transplant Diagnostics Market?

Major companies operating in the transplant diagnostics market include F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

What Are the Key Drivers of the Transplant Diagnostics Market?

The rise in chronic diseases is projected to fuel the expansion of the transplant diagnostics market. Chronic conditions are persistent health issues that often necessitate long-term management and treatment. They encompass illnesses such as diabetes, heart disease, asthma, and arthritis. These conditions are escalating due to factors like an aging demographic, an uptick in unhealthy living habits (such as poor nutrition, sedentary lifestyle, and smoking), and increased exposure to environmental toxins. Chronic ailments necessitate transplant diagnostics for the evaluation of organ function, compatibility, and potential transplant needs as a result of the enduring damage these disorders can inflict on essential organs. For example, research released by the American Cancer Society in January 2022 predicted that there would be 609,360 cancer-related deaths and 1.9 million new cancer incidences in the US in 2022, amounting to approximately 1,670 deaths per day. Consequently, the escalating prevalence of chronic diseases is a driving force behind the growth of the transplant diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2481&type=smp

What Are the Key Market Segments in the Transplant Diagnostics Industry?

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent And Consumables, Instrument, Software And Services

2) By Transplant Type: Solid Organ, Stem Cell

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non Molecular Assay, Molecular Assay

5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers

Subsegments:

1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials

2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

What Are the Latest Trends in the Transplant Diagnostics Market?

Prominent businesses in the transplant diagnostics industry are utilizing advanced transplant diagnostics services to enhance their market profitability. This refers to the incorporation of sophisticated and innovative diagnostic tools and technologies for increasing the precision and effectiveness of tests carried out pre and post-transplant. For example, Quest Diagnostics, a medical laboratory operating out of the US, initiated the Quest Advanced Specialized Transplant Services in March 2023. These services, aimed at increasing lab test accessibility for solid organ, human cell, and tissue transplants, offer a collection of more than 170 specific transplant and infectious disease tests. They facilitate longitudinal trend analysis of test outcomes in the physician’s electronic medical record (EMR) and offer 24/7 support services such as medical consultations for proper test selection and result interpretation. The newly introduced services extend upon the former testing services offered by Quest, including new features. Notably, these features are informative packets tailored to individual patients to guide them through the process and enable Quest’s phlebotomists to expedite testing at any of the 2,100 patient service centers. Some test results are available in a period ranging from 8 to 24 hours.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

What Are the Key Regional Markets in the Transplant Diagnostics Industry?

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2481

This Report Delivers Insight On:

1. How big is the transplant diagnostics market, and how is it changing globally?

2. Who are the major companies in the transplant diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the transplant diagnostics market right now?

4. Which products or customer segments are growing the most in the transplant diagnostics market?

5. What factors are helping or slowing down the growth of the transplant diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the transplant diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Transplant Diagnostics Market Expected to Grow Between 2025 And 2029?

In the past few years, the transplant diagnostics market has seen consistent growth. The market which was valued at $2.01 billion in 2024 is projected to increase to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 3.0%. Reasons for this growth in the historical timeframe include the advancement of hla typing, an increase in organ transplantations, improvements in immunosuppressive therapy, the introduction of cross-matching techniques, and regulatory standardization.

In the coming years, the transplant diagnostics market is anticipated to experience a robust growth, with its estimated worth reaching $2.75 billion by 2029. This growth, corresponding to a compound annual growth rate (CAGR) of 7.4%, can be linked to several factors such as a focus on patient-centric approaches, modifications in regulations, an increase in living donor transplants, customization in transplant medicine, and an expansion in transplant procedures. Noteworthy trends during the forecasted period include an emphasis on education and awareness campaigns, market growth strategies, alteration of regulatory guidelines, optimization of immunosuppressive therapy, and development of biomarkers.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

What Are the Core Growth Drivers Propelling the Transplant Diagnostics Market Forward?

The escalating occurrence of chronic disorders is anticipated to spur the expansion of the transplant diagnostics market. Chronic diseases, such as diabetes, heart disease, asthma, and arthritis, persist over a long period and often necessitate continued management and treatment. The upsurge in such diseases is associated with factors like an aging populace, a rise in unhealthy lifestyles entailing deficient nutrition, a lack of physical activity, and smoking, along with an increased exposure to environmental pollutants. Transplant diagnostics are critical for assessing organ functionality, compatibility, and potential transplant requirement due to the prolonged damage these diseases inflict on crucial organs. For instance, research by the American Cancer Society, a US-based health organization, revealed in January 2022 that it is estimated there will be 609,360 cancer deaths and 1.9 million new cancer incidents in the US in 2022, equivalent to roughly 1,670 deaths every day. Hence, the escalating incidence of chronic diseases propels the growth of the transplant diagnostic market.

What Segment Types Define the Transplant Diagnostics Market Structure?

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent And Consumables, Instrument, Software And Services

2) By Transplant Type: Solid Organ, Stem Cell

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non Molecular Assay, Molecular Assay

5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers

Subsegments:

1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials

2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2481&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Transplant Diagnostics Market?

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

Which Emerging Trends that Are Influencing the Transplant Diagnostics Industry Evolution?

Leading organizations within the transplant diagnostics market are concentrating on launching enhanced transplant diagnostics services to optimally capitalize on the industry. Enhanced transplant diagnostics services involve the application of state-of-the-art diagnostics tools and methodologies to augment the precision and efficacy of pre and post-transplant evaluations. For example, in March 2023, Quest Diagnostics, an American medical laboratory firm, unveiled its latest offering, Quest Advanced Specialized Transplant Services. This service includes a comprehensive array of inventive diagnostics and support services purposed to widen the availability of lab tests for solid organ, human cell, and tissue transplants. It offers a wide-ranging selection of over 170 specialized transplant and infectious disease tests, an in-depth trend analysis of test results in the physician’s electronic medical record (EMR), and 24/7 support services, incorporating medical consultation to facilitate accurate test selection and result interpretation influencing care decisions. The newly introduced services extend upon Quest’s existing transplant testing services with additional features. These features comprise patient-customized information packets meant to inform patients about the procedure and assist Quest’s phlebotomists in accelerating testing for patients who visit one of Quest’s 2,100 patient service centers. The results for certain tests can be received within a timeframe of 8–24 hours.

View the full report here:

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

What Is the Definition of the Transplant Diagnostics Market?

Transplant diagnostics are the tests conducted before relocation/ transplantation of the donor organ to the recipient patient. Histocompatibility and immunogenetics are the main topics of transplantation diagnostics in the context of organ transplantation and hematopoietic stem cell transplantation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2481

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the transplant diagnostics market grown over the years?

Over the past few years, there has been steady growth in the transplant diagnostics market size. The market is projected to increase from $2.01 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 3.0%. The historic period’s growth can be traced back to factors such as the development of hla typing, increase in organ transplantations, advancements in immunosuppressive therapy, introduction of cross-matching techniques, and regulatory standardization.

What Is the forecasted market size and growth rate for the transplant diagnostics market?

In the coming years, the transplant diagnostics market is projected to experience a robust expansion. The market is forecasted to reach a worth of $2.75 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.4%. This expected growth during the forecast period is a result of factors such as a focus on patient-centric strategies, changes in regulation, growth in living donor transplants, advancements in personalized transplant drugs, and an increase in transplant procedures. Key trends during this period will be the escalation of educational and awareness programs, the implementation of market expansion techniques, evolution of regulatory norms, the optimization of immunosuppressive therapy, and the development of new biomarkers.

Get your transplant diagnostics market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

What are the major factors driving growth in the transplant diagnostics market?

The escalating occurrence of enduring illnesses is presumed to spur the advancement of the transplant diagnostics market. Chronic diseases are persistent health problems that continue over a period of time and typically necessitate continuous supervision and therapy. These diseases can encompass ailments like diabetes, heart disease, asthma, and arthritis. The surge in chronic diseases can be attributed to factors such as an aging demographic, a rise in unhealthy lifestyle habits, which include poor eating habits, lack of physical activity, and smoking, as well as heightened exposure to environmental pollutants. Transplant diagnostics, which evaluate organ function, compatibility, and the possibility of a future need for transplant due to long-term organ damage, are essential in the management of chronic diseases. For example, research published by the American Cancer Society in January 2022, reveals that an expected 609,360 cancer-related deaths and 1.9 million new cancer instances are projected in 2022 in the US, translating into approximately 1,670 fatalities daily. Hence, the escalating occurrence of chronic diseases is propelling the expansion of the transplant diagnostics market.

What key areas define the segmentation of the global transplant diagnostics Market?

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent And Consumables, Instrument, Software And Services

2) By Transplant Type: Solid Organ, Stem Cell

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non Molecular Assay, Molecular Assay

5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers

Subsegments:

1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials

2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

What are the top market players propelling the growth of the transplant diagnostics industry?

Major companies operating in the transplant diagnostics market include F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

What are the key trends shaping the future of the transplant diagnostics market?

Leading firms in the transplant diagnostics market are striving to launch state-of-the-art services in order to increase their market gains. This involves employing innovative diagnostic tools and technologies to enhance the precision and efficiency of pre and post-transplant testing. For instance, Quest Diagnostics, an American medical lab company, unveiled the Quest Advanced Specialized Transplant Services in March 2023. This is a comprehensive suite of cutting-edge diagnostics and supportive services designed to expand the reach of lab tests for solid organ, human cell, and tissue transplants. The service offers more than 170 specific transplant and infectious disease tests, longitudinal trend analysis of tests within a doctor’s electronic health records (EHR), and continuous services support, inclusive of medical consultation to guarantee proper test selection and result interpretation. This service complements Quest’s existing transplant testing service but with added features. Among these are personalized educational packets for patients and accelerated testing for patients at any of Quest’s 2,100 patient service centers. The turn-around time for some tests ranges from 8–24 hours.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2481

What regions are dominating the transplant diagnostics market growth?

North America was the largest region in the transplant diagnostics market in 2024. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Microbiology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Oncology Molecular Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Are the Projected Expansion Rates of the Transplant Diagnostics Market for the Next Decade?

Over the past few years, there has been steady growth in the transplant diagnostics market size. The market is projected to increase from $2.01 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 3.0%. The historic period’s growth can be traced back to factors such as the development of hla typing, increase in organ transplantations, advancements in immunosuppressive therapy, introduction of cross-matching techniques, and regulatory standardization.

In the coming years, the transplant diagnostics market is projected to experience a robust expansion. The market is forecasted to reach a worth of $2.75 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.4%. This expected growth during the forecast period is a result of factors such as a focus on patient-centric strategies, changes in regulation, growth in living donor transplants, advancements in personalized transplant drugs, and an increase in transplant procedures. Key trends during this period will be the escalation of educational and awareness programs, the implementation of market expansion techniques, evolution of regulatory norms, the optimization of immunosuppressive therapy, and the development of new biomarkers.

What Are the Primary Drivers Supporting the Growth of the Transplant Diagnostics Market?

The escalating occurrence of enduring illnesses is presumed to spur the advancement of the transplant diagnostics market. Chronic diseases are persistent health problems that continue over a period of time and typically necessitate continuous supervision and therapy. These diseases can encompass ailments like diabetes, heart disease, asthma, and arthritis. The surge in chronic diseases can be attributed to factors such as an aging demographic, a rise in unhealthy lifestyle habits, which include poor eating habits, lack of physical activity, and smoking, as well as heightened exposure to environmental pollutants. Transplant diagnostics, which evaluate organ function, compatibility, and the possibility of a future need for transplant due to long-term organ damage, are essential in the management of chronic diseases. For example, research published by the American Cancer Society in January 2022, reveals that an expected 609,360 cancer-related deaths and 1.9 million new cancer instances are projected in 2022 in the US, translating into approximately 1,670 fatalities daily. Hence, the escalating occurrence of chronic diseases is propelling the expansion of the transplant diagnostics market.

Explore Comprehensive Insights Into The Global Transplant Diagnostics Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

Which Companies Are Redefining the Future of the Transplant Diagnostics Market?

Major companies operating in the transplant diagnostics market include F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

How Are Market Trends and Shifts Impacting the Growth Trajectory of the Transplant Diagnostics Market?

Leading firms in the transplant diagnostics market are striving to launch state-of-the-art services in order to increase their market gains. This involves employing innovative diagnostic tools and technologies to enhance the precision and efficiency of pre and post-transplant testing. For instance, Quest Diagnostics, an American medical lab company, unveiled the Quest Advanced Specialized Transplant Services in March 2023. This is a comprehensive suite of cutting-edge diagnostics and supportive services designed to expand the reach of lab tests for solid organ, human cell, and tissue transplants. The service offers more than 170 specific transplant and infectious disease tests, longitudinal trend analysis of tests within a doctor’s electronic health records (EHR), and continuous services support, inclusive of medical consultation to guarantee proper test selection and result interpretation. This service complements Quest’s existing transplant testing service but with added features. Among these are personalized educational packets for patients and accelerated testing for patients at any of Quest’s 2,100 patient service centers. The turn-around time for some tests ranges from 8–24 hours.

Secure Your Global Transplant Diagnostics Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Transplant Diagnostics Market?

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent And Consumables, Instrument, Software And Services

2) By Transplant Type: Solid Organ, Stem Cell

3) By Organ: Kidney, Liver, Heart, Lung, Pancreas

4) By Technology: Non Molecular Assay, Molecular Assay

5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers

Subsegments:

1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials

2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

What Are the Leading Regions in the Transplant Diagnostics Market Expansion?

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

How Is the Transplant Diagnostics Market Classified and Defined in Market Analysis?

Transplant diagnostics are the tests conducted before relocation/ transplantation of the donor organ to the recipient patient. Histocompatibility and immunogenetics are the main topics of transplantation diagnostics in the context of organ transplantation and hematopoietic stem cell transplantation.

Browse Through More Similar Reports By The Business Research Company:

Microbiology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Oncology Molecular Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: